Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Changes in the Cutaneous Nerve Fiber Staining and Distribution of PGP9.5 in Clinically Uninvolved Skin in Leprosy Patients after Completion of Multidrug Therapy and Assessing PGP9.5 as a Marker of Treatment Response.

Thakur V, Narang T, Bishnoi A, et al. Indian dermatology online journal. 2024; 15 (4) : 599-604.
Download PDF
Publication

Impact of COVID-19 on the neglected tropical diseases: a scoping review

Butala CB, Cave RNR, Fyfe J, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2024; 13 (1) : 1-16.
Download PDF
Publication

Doenças tropicais negligenciadas e a relação com o índice de desenvolvimento humano na Região Norte do Brasil

de Sousa GVMA, Ferreira MCS, Lima MEO, et al. Seven Congress. IV Seven International Congress of Health. 2024;
Download PDF
Publication

Análise Epidemiológica da Hanseníase em Goiânia de 2016 a 2020: Estratégia de Intervenção Através de Revisão Sistemática

Facure CG, Alencar PESD, Carneiro TB, et al. Revista Ibero-Americana de Humanidades, Ciencias e Educacao. Revista Ibero-Americana de Humanidades, Ciências e Educação. 2024; 10 (7) : 2902-2916.
Download PDF
Publication

Exploring Active Case Detection Approaches for Leprosy Diagnosis in Varied Endemic Settings: A Comprehensive Scoping Review

Brown H, Fastenau A, Penna S, et al. MDPI AG. Life. 2024; 14 (8) : 1-15.
Download PDF
Publication

Fenômeno de Lúcio: relato de caso

Almeida Pastana R, Bezerra JV, Zimermano Coimbra B, et al. Brazilian Journal of Health Review. 2024;
Download PDF
Publication

Caracterização e geoespacialização dos casos notificados de hanseníase nos estados norte e nordeste entre os anos de 2019 a 2023

Oliveira Guimarães MF, Lima dos Santos AC, dos Santos Guimarães ACO, et al. Revista Brasileira Medicina de Excelência . 2024;
Download PDF
Publication

Borderline lepromatous leprosy: A case report

Fernando N, Welhenge C, Premaratna R, et al. Medknow. Asian Pacific Journal of Tropical Medicine. 2024; 17 (7) : 329-332.
Download PDF
Publication

Is there a lack of a glucose monitoring and management protocol for preventing hyperglycemia and glucocorticoid-induced diabetes mellitus in leprosy reactions?

Antunes DE, Santos DFD, Thomazelli JA, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2024; 18 (7) : 1-6.
Download PDF
Publication

Impacto da pandemia da covid-19 sobre a adesão ao tratamento da hanseníase em um hospital público do Distrito Federal

Pereira JF. Universidade de Brasília. 2023;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 87
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD